Hissey Kientz, LLP Announces the Launch of Digitek Recall Hel... ( The law firm o...)

Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site

Date:9/23/2008

The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. The drug's manufacturer issued a nationwide Digitek recall after receiving several reports of injuries or illnesses among patients.

Austin, Texas (Vocus) September 23, 2008 -- The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). This site will serve as a news and information resource for patients who may have been prescribed the improperly manufactured Digitek (digoxin) tablets that were recently recalled by their maker, Actavis Totowa.

Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. Digitek and other digoxin drugs work by increasing the amount of calcium in the muscles of the heart, which helps to strengthen a patient’s heartbeat. These drugs also work to slow the signals which cause the heart to beat, decreasing the number of irregular heartbeats, or arrhythmias.

Actavis issued a nationwide http://www.digitekrecallhelp.com/Recall.aspx [Digitek recall] on April 25, 2008 after receiving several reports of injuries or illnesses among patients who were taking the drug. According to a press release issued by the company, some Digitek tablets were improperly manufactured at twice their normal thickness. As a result, some patients who were prescribed Digitek may have inadvertently received a double-dose of the drug.

Because the difference between a safe and unsafe amount of Digitek is very small, taking these double-strength pills could cause patients to suffer an ove
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

2

GOOD

Page: 1 2 3
Related medicine news :

1. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
2. LifeMasters Announces Agreement to Offer Disease Management Services to High-Risk Wisconsin Residents
3. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
4. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
5. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
6. Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
7. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
8. CorVel Announces Expanded Share Buyback
9. Lucas Group Announces Their Military Hiring Conferences Schedule for September
10. Integrative Nutrition Announces Partnership with SUNY
11. iMedica Announces Agreement with Misys

Post Your Comments:

Related Image:

Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site

(Date:11/29/2009)...treatment equals a $41,000 pay raise, researchers ...s) -- Psychological therapy may be much more effec...r winning a lottery prize, suggests an English stu... people who provided information about their menta...ess from a $1,329 course of therapy was so signifi...

(Date:11/29/2009)...nal healthcare,s uncertain future and rising costs...are. Affordable Acupuncture Scottsdale answers the... 29, 2009 -- Affordable Acupuncture, LLC opened in...en met with enthusiasm and gratitude. Its increasi...to two things, need and cost. "As far as I&r...

(Date:11/28/2009)...to consider change after 30-minute psychosocial in... 27 (HealthDay News) -- A program that gets persis...p their dangerous behavior may lead to significant... , The new study included 184 men and women wit...who were randomly assigned to one of two intervent...

(Date:11/27/2009)...27 GSI Group Inc. (Pink ...sion technology products and semiconductor systems...mpany,s shareholders has been scheduled for Friday...eting will be announced in due course. As previou...notice from Stephen Bershad, a holder of greater t...

(Date:11/27/2009)...swire-USNewswire/ -- Considered a highly risky and..., solid organ transplantation is now a life-saving...men and women who gathered at the Winspear Opera H...rom medical centers around the world to celebrate ... Institute (BRTI), one of the pioneers of solid or...

Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2 Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2 Health News:Drunk Drivers May Respond to Brief Motivational Interview 2 Health News:GSI Group Calls Shareholders Meeting 2 Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2 Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3

[0] Psychotherapy Can Boost Happiness More Than Money: Study [0] Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities [1] Drunk Drivers May Respond to Brief Motivational Interview [0] GSI Group Calls Shareholders Meeting [0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary

... an associate professor of medicine at Boston Univ...an in the General Internal Medicine Department at ...director of the Substance Abuse Prevention and Tre...esented at the American Association for the Treatm...

...f of patients, study found , TUESDAY, Oct. 30 (Hea...ib shows promise for treating people with what,s k...er -- a group of patients who typically have a poo... and 3. , As reported in the November issue of T...

...bariatric surgeries to high-volume centers disprop...red patients, populations which are among the most...rn Medical Center researchers shows. , Government...d because some studies have identified better outc...

...E: STE ) today announced financial results for it...007. Fiscal 2008 second quarter revenues,increased... in the second,quarter of fiscal 2007, primarily d...d with net income of $16.4 million, or $0.25 per,d...

...daq(R) Technologies Inc.,(TSX: NDQ), a developer o...ed,therapies for the operating room, will host a c...ancial results for the third quarter ended Septemb...lay: 416-640-1917 or 1-877-289-8525 (Available ...

...ink Sheets: HRAL) announced that it has received a...owned subsidiary of Wal-Mart International, Inc.,(...g-aid clinics in two,Toronto area Wal-Mart Stores.... will both officially open today. This,expansion i...

Boston University School of Medicine physician receives award from AATOD New Drug Promising Against Tough-to-Treat Kidney Cancer Government restrictions on weight loss surgeries limit access for poor, underinsured patients STERIS Corporation Announces Fiscal 2008 Second Quarter Results Novadaq announces third quarter 2007 conference call and webcast HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053

(Date:11/25/2009)...wswire-FirstCall/ -- American Scientific Resources...ed to announce that they have opened a regional ma...ai, China. ,, ASR has been able to secure a loc...he development and production of current and futur...ts to be distributed and sold globally. Currently...

(Date:11/25/2009)...wire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS...ted to discovering, developing and commercializing...inancial results for the fiscal year ended Septemb... $58.4 million in cash, cash equivalents and short...9 Highlights ,, RG7128 ,, Phase 2b Tria...

(Date:11/25/2009)... -- BioTrends Research Group, Inc. released Wave 1...the first in a multi-phase syndicated market resea...Biotech,s Stelara, from product launch through the...he report provides quantitative information from 7...n from a subset of 20. The reports assess trial a...

[0] American Scientific Resources Inc. Opens Shanghai Location [0] Pharmasset Reports Fiscal Year End 2009 Financial Results [0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High

... IIa Clinical Trial in Type 2,Diabetes Patients An...all/ - Transition,Therapeutics Inc. ("Transition")...y Phase IIa clinical trial indicating that 4-weeks...1-I.N.T.(TM), showed,sustained reductions in blood...A1C (HbA1c), for 6 months post-treatment. The type...

...-(BUSINESS WIRE)--Jun 28, 2007,- Progenics Pharmac...icals, a division of Wyeth (NYSE: WYE), today anno...el extension study of,subcutaneous methylnaltrexon... (OIC) in patients with advanced illness. The resu...onal Association of,Supportive Care in Cancer (MAS...

Other Medicine Technology:A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2 A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3 A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4 A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5 Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 2 Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 3 Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 4 Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 5 Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 6

A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness

VS-1/IS-1 Plug

Universal Adaptor Sleeve

Silicone - End Caps

...biatrial stimulation. This is the first implant fo...s. The patients benefit from a lasting improvement...ainst cardiac remodeling. Tupos LA uses biatrial s...ptomatic and medicine resistant atrial tachycardia...

Medicine Products:

VS-1/IS-1 Plug Universal Adaptor Sleeve Silicone - End Caps Tupos LA

Hissey Kientz, LLP Announces the Launch of Digitek Recall Hel...( The law firm o...),Health